Advocacy

The U.S. Department of Health and Human Services (HHS) has unveiled an ambitious initiative aimed at restoring America's leadership in clinical...

As a member of the Council of State Bioscience Associations (CSBA), MichBio recently joined bioscience organizations from across the country in...

Michigan’s own U.S. Representatives John Moolenaar (R-MI) and Debbie Dingell (D-MI) recently introduced the Biotech Investment National...

A new proposal under consideration at the National Institutes of Health (NIH) is generating intense discussion across the nation's biomedical...

Medical device manufacturers, suppliers, healthcare providers, and investors are closely monitoring a federal trade investigation that could...

/*SLIDER */ .testimonial-slider { display: block; width: 100%; height: auto; margin-top:0px; display: -ms-flexbox; ...

The Trump administration is advancing one of the most significant restructurings of the federal grantmaking system in decades, proposing changes...

Michigan Congressman John Moolenaar, Chair of the House Select Committee on the Chinese Communist Party, has introduced the Securing Innovation...

The House Energy & Commerce Committee’s Health Subcommittee has advanced bipartisan legislation aimed at accelerating the FDA’s...

For decades, drug development has followed a predictable cadence: run a trial, wait, analyze, submit. Progress has often been defined as much by...

Momentum in Congress around Medicare coverage reform for medical devices appears to have slowed following the Administration’s introduction...

As the Michigan Senate considers the FY budget for the Department of Health and Human Services, MichBio is raising strong concerns about the...